Qualcomm and Arm are back in court

Back in the courtroom

Qualcomm and Arm are starting a fresh trial over chip testing tools, which is corporate America’s version of arguing over who gets to use the good kitchen gadgets in the office break room. It’s not glamorous, but it can still matter a lot for the economics of the chip business.

Why you should care

At the center of the fight is control over tools and rights tied to Qualcomm’s chip development process. If the dispute turns into tougher licensing terms or added friction, that can influence margins, product planning, and the broader relationship between two companies that have to keep doing business even while staring each other down in court.

Same soap opera, new episode

This isn’t exactly a brand-new franchise. Qualcomm and Arm have been circling each other in legal battles before, and the latest trial adds another layer to an already messy relationship. For investors, that means more headline risk, more uncertainty around licensing, and fewer chances for this to quietly disappear behind the scenes.

Big picture: when two chip giants end up arguing in public, the real cost isn’t just legal bills — it’s the possibility that the rules of the road for future chips get more expensive or less predictable.